Objectives: We compared a 3rd generation (gen) and two 4th gen HIV enzyme immunoassays (EIA) to pooled nucleic acid testing (PNAT) for the identification of pre- and early seroconversion acute HIV infection (AHI).
Study Design: 9550 specimens from males >18 year from clinics attended by men who have sex with men were tested by Siemens ADVIA Centaur(®) HIV 1/O/2 (3rd gen) and HIV Combo (4th gen), as well as by Abbott ARCHITECT(®) HIV Ag/Ab Combo (4th gen). Third gen non-reactive specimens were also tested by Roche COBAS(®) Ampliprep/COBAS® TaqMan HIV-1 Test v.2 in pools of 24 samples. Sensitivity and specificity of the three EIAs for AHI detection were compared.
Results: 7348 persons contributed 9435 specimens and had no evidence of HIV infection, 79 (94 specimens) had established HIV infection, 6 (9 specimens) had pre-seroconversion AHI and 9 (12 specimens) had early seroconversion AHI. Pre-seroconversion AHI cases were not detected by 3rd gen EIA, whereas 2/6 (33.3%) were detected by Siemens 4th gen, 4/6 (66.7%) by Abbott 4th gen and 6/6 (100%) by PNAT. All three EIAs and PNAT detected all individuals with early seroconversion AHI. Overall sensitivity/specificity for the EIAs relative to WB or NAT resolved infection status was 93.6%/99.9% for Siemens 3rd gen, 95.7%/99.7% for Siemens 4th gen and 97.9%/99.2% for Abbott 4th gen.
Conclusions: While both 4th gen EIAs demonstrated improved sensitivity for AHI compared to 3rd gen EIA, PNAT identified more AHI cases than either 4th gen assay. PNAT is likely to remain a useful strategy to identify AHI in high-risk populations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcv.2014.06.024 | DOI Listing |
J Gen Intern Med
January 2025
Department of Primary Care and Emergency Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Purpose: Our purpose was to evaluate the characteristics of highly and poorly rated teachers as well as to assess the validity and reliability of those evaluations.
Methods: We downloaded 14 years of medicine faculty evaluations completed by 3rd and 4 year medical students. We dichotomized overall teaching effectiveness as outstanding (receiving "outstanding") or inferior (rated as a "unsatisfactory," "marginal," or "acceptable").
Gen Thorac Cardiovasc Surg Cases
October 2024
Second Department of Surgery, University of Occupational and Environmental Health, Kitakyushu, Japan.
Background: Durvalumab after chemoradiation (PACIFIC regimen) provides favorable treatment outcomes for unresectable stage III non-small cell lung cancer (NSCLC). The feasibility of salvage surgery after the PACIFIC regimen has been reported in some studies; however, its efficacy remains unclear. We herein present the first case of salvage surgery after the PACIFIC regimen for a superior sulcus tumor with N3 involvement, in which a pathological complete response was achieved.
View Article and Find Full Text PDFZookeys
October 2024
Wildlife Aware Nature Club, Tumakuru 572101, Karnataka, India.
We describe a new plexippine genus, , supported by phylogenomic data from ultraconserved elements (UCEs), Sanger sequences of four genes, and morphological evidence. The type species, (Caleb, Christudhas, Laltanpuii & Chitra, 2014), is transferred from , as is (Caleb, 2022), The phylogenomic data places among the plexippines near C.L.
View Article and Find Full Text PDFBioorg Med Chem Lett
November 2024
State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing 100029, China. Electronic address:
The EGFR-TK pathway is pivotal in non-small-cell lung cancer (NSCLC) treatment, drugs targeting both EGFR wild-type and mutant tumor cells are still urgently needed. The focus of our study is on ATP-competitive inhibitors crucial for NSCLC therapy, specifically targeting the epidermal growth factor receptor (EGFR). A series of derivatives of Erlotinib and Icotinib were developed by incorporating a macrocyclic polyamine into a quinazoline scaffold to enhance their inhibitory activity against drug-resistant cells.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!